Global Septic Shock Clinical Trials Review, H2, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Septic Shock Global Clinical Trials Review, H2, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. The clinical…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Septic Shock Global Clinical Trials Review, H2, 2019” clinical trials has been added to ResearchAndMarkets.com’s offering. The clinical…
SAN JOSE, Calif. & JERUSALEM–(BUSINESS WIRE)–#Accellix–Accellix, Inc. is launching its Next Generation Integrated Accellix Instrument and Consumables to further automate,…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a clinical stage biopharmaceutical company focused on the development of therapies to improve the lives of…
Collaboration includes joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity Catalent to…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address…
Version 19 offers mechanistic models for assessing maternal-fetal drug risk, developing drug formulations, and optimizing dermal and transdermal drug development…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
AJOVY™ is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive treatment of migraine…
NEW YORK–(BUSINESS WIRE)–Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet…